SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Blueprint Medicines Announces FDA Approval Of AYVAKIT For Treatment Of Adults With Unresectable Or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor

Benzinga · 01/09/2020 20:53